Imagine this: a man in his late 30s visits a clinic after months of fatigue, low sex drive, and difficulty concentrating. Blood tests confirm that his testosterone is low. His doctor discusses testosterone replacement therapy, which may help improve some of those symptoms.
But there is one question that could change the treatment plan: Does he want to have children?
It may seem unrelated to a conversation about testosterone, particularly for men who aren’t currently trying to conceive. But testosterone replacement therapy (TRT) can reduce sperm production, sometimes to the point where no sperm are detected in semen.
The effect is well documented, although recovery after treatment varies considerably.
So, for men considering TRT, fertility deserves attention before that first prescription, not months or years later when starting a family already becomes a priority.
How testosterone affects sperm production
Now, let’s take a look at the connection between TRT and fertility. Testosterone is essential for male reproductive health, but the body needs more than adequate testosterone levels in the bloodstream to produce sperm.
This biological process needs a hormonal communication system between the brain and the testicles. The pituitary gland releases two hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH signals the testicles to produce testosterone, while FSH supports the cells involved in sperm development. Together, these signals help maintain the conditions needed for normal sperm production.
When testosterone is introduced from the outside: through injections, gels, or other replacement formulations, the brain detects the additional hormone and reduces its own signaling. This can cause LH and FSH levels to fall substantially. As a result, the testicles may produce less of their own testosterone, including the high concentrations needed locally for sperm development. Sperm production may decline or stop.
This can happen even when blood tests show that testosterone levels are normal or elevated. In other words, having enough testosterone in the bloodstream doesn’t necessarily mean a man is producing enough sperm.
How common is infertility during TRT?
This is not a one-size-fits-all. The extent of sperm suppression differs between patients. Some men experience a considerable reduction in sperm count, while others develop azoospermia, a condition in which no sperm are detected in the ejaculate.
A 2025 review published in Nature Reviews Urology examined the relationship between testosterone replacement therapy and sperm production in reproductive-age men.
The researchers described how external testosterone suppresses the hormonal signals needed for sperm development. They also emphasized that recovery after treatment can be unpredictable, particularly among men who have used testosterone for extended periods.
These findings reinforce guidance from the American Urological Association and the American Society for Reproductive Medicine.
Their 2024 updated male infertility guideline advises against prescribing external testosterone to men interested in current or future fertility.
For men hoping to conceive soon, the recommendation is especially relevant. But what about someone who might want children five years from now?
Again, that situation calls for an individual discussion. Fertility plans may change, and the effects of testosterone therapy are not always immediately reversible.
Does fertility return after stopping TRT?
It is important to start this section by saying that a return to previous sperm counts is not guaranteed. For many men, sperm production gradually resumes once external testosterone is discontinued. The difficulty is predicting how long that recovery will take. Some men recover within several months. Others need a year or longer, particularly following prolonged testosterone exposure.
Recovery depends on several factors, including age, underlying reproductive health, duration of treatment, and whether fertility problems existed before TRT.
There is also a distinction between sperm production returning and fertility returning to normal.
A semen sample may show that sperm are present again, but the concentration or quality may still be insufficient for conception.
The 2025 Nature Reviews Urology review noted that some men may experience prolonged recovery or fail to return to their previous level of sperm production.
For couples hoping to conceive within a particular timeframe, that uncertainty matters.
Stopping testosterone doesn’t provide an immediate solution, and patients should not discontinue prescribed treatment without discussing a plan with their clinician.
Can HCG help preserve fertility?
If you start looking more into this, you will definitely stumble on HCG. This is a treatment that has attracted attention in discussions about TRT fertility. HCG stands for human chorionic gonadotropin.
Although HCG is best known as a hormone associated with pregnancy, it also has medical applications in men. HCG acts similarly to luteinizing hormone, stimulating testosterone production within the testicles.
That distinction is important because sperm production depends partly on maintaining adequate testosterone levels inside the testicles, not simply in the bloodstream. In certain cases, clinicians use HCG to help manage specific forms of male hypogonadism or infertility. Some smaller studies have also investigated whether HCG can help maintain sperm production in men receiving testosterone therapy.
The results have shown potential, but the evidence remains limited.
The AUA/ASRM guideline notes that HCG and certain other hormonal medications may be considered for infertile men with low testosterone. However, evidence supporting the routine addition of HCG to TRT for fertility preservation is insufficient to recommend that approach broadly.
HCG is not a guarantee against infertility.
Its use alongside testosterone to preserve fertility may also be off-label, depending on the indication and product.
Patients interested in clinician-guided HCG treatment options should receive an individualized evaluation rather than assuming that combining two medications will protect sperm production.
The underlying cause of low testosterone, existing sperm counts, and reproductive goals all influence whether HCG or another approach may be appropriate.
What should men ask before starting TRT?
These conversations should begin with fertility plans, even when those plans are uncertain.
A man who expects to have children within the next year has different treatment considerations from someone who has completed his family. Doctors should also establish whether the patient has an existing fertility problem.
A semen analysis can provide useful information about sperm concentration, movement, and other characteristics. Unlike a standard testosterone blood test, it directly assesses aspects of sperm production.
For men concerned about future fertility, a baseline semen analysis may help inform treatment decisions.
Sperm banking is another option worth discussing before starting testosterone.
Freezing sperm does not prevent TRT-related suppression, but it may provide a reproductive option if natural sperm production later becomes impaired. Costs, storage arrangements, and future fertility treatment requirements should be considered.
There is no single fertility preservation strategy that suits every patient.
Men with diagnosed testosterone deficiency may benefit from consulting a reproductive urologist or fertility specialist before beginning treatment, particularly if they already have abnormal semen results or a history of difficulty conceiving.
Are there alternatives to traditional TRT?
For men who need treatment for low testosterone but want to preserve fertility as a priority, external testosterone may not be the preferred first option. But there are other.
Depending on the diagnosis, clinicians may consider medications that stimulate the body’s own testosterone production rather than replacing testosterone directly.
These include HCG and certain selective estrogen receptor modulators, or SERMs, which influence hormonal signaling.
The distinction is especially relevant in secondary hypogonadism, where the testicles may still be capable of producing testosterone but are receiving inadequate hormonal signals.
However, these treatments are not appropriate for every cause of testosterone deficiency. Some uses are off-label, and clinical outcomes depend on the patient’s underlying condition.
For men considering testosterone replacement therapy, understanding these differences can help make the initial treatment discussion more productive.
The question is not simply which medication raises testosterone levels.
It is which approach is medically appropriate while accounting for the patient’s reproductive plans.
Why fertility should remain part of follow-up care
Fertility concerns don’t necessarily end after the first appointment.
A patient may begin treatment with no immediate plans for children and reconsider several years later. Others may discover that their reproductive goals are different from those discussed when treatment began.
That makes ongoing communication important.
Routine TRT blood tests monitor factors such as testosterone levels and hematocrit, but they do not establish whether sperm production has been preserved.
A semen analysis may be necessary when fertility becomes a concern.
Patients should also be aware that having normal sexual function doesn’t confirm normal fertility. Libido, erections, and sperm production are related to reproductive health, but they are not interchangeable measures.
A man may feel better during TRT while producing very few sperm.
Without appropriate testing, he may have no reason to suspect that his fertility has changed.
Making the decision before treatment begins
TRT can be an appropriate medical treatment for men with confirmed hypogonadism. But its effects on the reproductive system need to be considered alongside its potential benefits.
The evidence is clear that external testosterone can suppress sperm production. What remains less predictable is how strongly an individual patient will be affected and how completely fertility will recover afterward.
HCG and other treatments may offer alternatives in selected cases, but they require specialist assessment and cannot eliminate all uncertainty.
For men considering TRT, the most useful first step may be a conversation that has nothing to do with their current testosterone number.
Whether they want children, when they might want them, and what options are available to protect future fertility. A lot can depend on those answers.
